Chronic itching associated with diabetes in mice was reduced after blocking P2Y12 with ticagrelor or P2Y12 shRNA, indicating a change in the expression of P2Y12 through anti-inflammatory cytokine activities [136]. Here, P2RY12 is linked to diabetes mellitus.